Overexpression of BRD4 was found in melanoma, and downregulation of BRD4 by genetic knockdown is sufficient to recapitulate the antitumoral effect of BET inhibitors in melanoma cell (Segura et al., 2013). The gene discussed is DNER; the disease is melanoma.